Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Bristol-Myers Squibb (NY:BMY)

47.85 +1.30 (+2.79%)
Official Closing Price Updated: 6:30 PM EDT, Aug 13, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 10,108,275
Open 46.74
Bid (Size) 47.52 (4)
Ask (Size) 47.78 (6)
Prev. Close 46.55
Today's Range 46.35 - 47.87
52wk Range 42.96 - 63.30
Shares Outstanding 2,222,113,553
Dividend Yield 5.18%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
10 Health Care Stocks Whale Activity In Today's Session
 
Via Benzinga
Want Over $2,100 in Annual Dividends? Invest $12,000 Into Each of These 3 High-Yielding Stocks
The dividend stocks listed below all yield more than 5% and look like safe long-term buys. 
Via The Motley Fool

Performance

YTD
-15.7%
-15.7%
1 Month
+1.1%
+1.1%
3 Month
+2.7%
+2.7%
6 Month
-14.5%
-14.5%
1 Year
+1.7%
+1.7%

More News

Read More
BMY Q2 Deep Dive: Pipeline Progress, Guidance Revision, and Strategic Partnerships Shape Outlook
Via StockStory
Sanofi, Eli Lilly, Novo Nordisk, AstraZeneca Face Renewed Claims Of Conspiring To Restrict 340B Discounts
Via Benzinga
Topics Lawsuit
Meta, Microsoft Power Wall Street To New Records Despite Inflation Jump: What's Moving Markets Thursday?
Via Benzinga
Topics Economy
PRME Revenue Misses by 73%
Via The Motley Fool
Is It Time to Buy Biotech Stocks?
Via The Motley Fool
RFK Jr. Sued By Eli Lilly, Amgen Over Drug Discount Program
Via Benzinga
Topics Lawsuit
1 Small-Cap Biotech Stock Poised for a Breakout
Via The Motley Fool
Topics Economy
Bristol Myers Squibb’s Application for Breyanzi (lisocabtagene maraleucel) Accepted for Priority Review by U.S. Food and Drug Administration (FDA) in Fifth Cancer Type for Relapsed or Refractory Marginal Zone Lymphoma (MZL)
From Bristol Myers Squibb
Via Business Wire
Why Is Replimune Stock Trading Lower On Monday?
Via Benzinga
BioNTech Narrows Losses, Q2 Revenue Doubles As Vaccine Collaboration Drives Growth
Via Benzinga
Late-Stage Pipeline Wins Boost Investor Confidence in High-Growth Therapeutic Areas
Via Investor Brand Network
Topics Government
Late-Stage Pipeline Wins Boost Investor Confidence in High-Growth Therapeutic Areas
Via FinancialNewsMedia
Topics Government
This Biotech Stock Could Soar on Upcoming Clinical Data
Via The Motley Fool
Bristol Myers (BMY) Q2 EPS Jumps 36%
Via The Motley Fool
Topics Intellectual Property
Trump Issues 60 Day Ultimatum To US Pharma Giants To Slash Drug Prices: 'If You Refuse To Step Up We Will...'
Via Benzinga
Topics Government
Trump Turns Up Heat On Big Pharma CEOs To Slash Drug Prices Within 60 Days — But Retail Traders Don't Flinch
Via Stocktwits
Topics Government
Bristol-Myers Squibb Unusual Options Activity For July 31
Via Benzinga
Why Bristol-Myers Squibb (BMY) Stock Is Trading Lower Today
Via StockStory
Topics Intellectual Property World Trade
Bristol-Myers Squibb (NYSE:BMY) Reports Strong Q2, Full-Year Sales Guidance is Optimistic
Via StockStory
Bristol Myers Cuts Earnings Outlook As Legacy Drugs Face Generic Erosion
Via Benzinga
Bristol-Myers Squibb Co (NYSE:BMY) Surpasses Q2 2025 Earnings and Revenue Estimates, Shares Rise in Pre-Market Trading
Via Chartmill
BRISTOL-MYERS SQUIBB CO (NYSE:BMY) – A High-Yield Dividend Stock with Strong Profitability and Financial Health
Via Chartmill
Bristol Myers Squibb Reports Second Quarter Financial Results for 2025
From Bristol Myers Squibb
Via Business Wire

Frequently Asked Questions

Is Bristol-Myers Squibb publicly traded?
Yes, Bristol-Myers Squibb is publicly traded.
What exchange does Bristol-Myers Squibb trade on?
Bristol-Myers Squibb trades on the New York Stock Exchange
What is the ticker symbol for Bristol-Myers Squibb?
The ticker symbol for Bristol-Myers Squibb is BMY on the New York Stock Exchange
What is the current price of Bristol-Myers Squibb?
The current price of Bristol-Myers Squibb is 47.85
When was Bristol-Myers Squibb last traded?
The last trade of Bristol-Myers Squibb was at 08/13/25 06:30 PM ET
What is the market capitalization of Bristol-Myers Squibb?
The market capitalization of Bristol-Myers Squibb is 106.33B
How many shares of Bristol-Myers Squibb are outstanding?
Bristol-Myers Squibb has 106B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.